Methotrexate is a globally recognized therapy in oncology and autoimmune disorders. Traditionally available as tablets or injections, it often poses challenges in dosing and administration—especially ...

Beta Drugs Ltd (NSE:BETA) reported a 13% increase in total sales, reaching 204 crores compared to 180 crores in the previous year. The company's EBITDA margins improved from 22.36% to 23.08%, ...

The latest announcement is out from Beta Drugs Ltd. ( (IN:BETA)). Beta Drugs Limited has scheduled a board meeting on January 9, 2026 at its corporate office in Panchkula to consider several strategic ...

Get the latest news today on Beta Drugs Ltd. Follow Business Standard for the complete news coverage and key information about the Beta Drugs Ltd.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Beta Drugs Ltd Share Price - Find the latest news updates, announcements & stock analysis for Beta Drugs Ltd, including market cap, share holding pattern, balance sheet, profit & loss, ...

Beta Drugs Ltd. engages in the manufacturing and trading of pharmaceuticals. The firm focuses on manufacturing oncology and dermatology medicines. Its products include adside etoposide, adrea hydroxy ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Beta Drugs Ltd. Annual stock financials by MarketWatch. View the latest BETA financial statements, income statements and financial ratios.

Beta Drugs Ltd. Annual cash flow by MarketWatch. View BETA net cash flow, operating cash flow, operating expenses and cash dividends.